Titan Biotech Limited intimates BSE about its board meeting scheduled for May 30, 2026 to approve FY26 financial results.
The board will consider recommending dividend on equity shares for the financial year ended March 31, 2026.
Trading window for designated persons has been closed since April 1, 2026 and will reopen 48 hours after results declaration.